Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Control and prevention of type 2 diabetes by inhibition of adipose tissue inflammation through diacerein
TCTR20200820004Completed
- Sponsor
- N/A
- Start
- Jul 2014
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of diacerein in type 2 diabetes mellitus (T2DM), sponsored by N/A. Started Jul 2014; status: completed.
02
Drugs
diacerein
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20200820004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200820004.